Health TrialsbyHealthPanel

An Advanced Decision Support Tool for Personalized Medicine for IVF Using Modeling and Optimization for Provera

ConditionInfertility (IVF Patients)
Trial statusRecruiting
Trial phasePhase 1, Phase 2
Trial typeInterventional
Biological sexFemale
Age20-50
SponsorUrmila DIwekar

About this trial

A clinical trial will determine the effectiveness of using the Opt-IVF decision support tool for each patient's personalized and optimal drug dosage profile in the United States.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

infertile women

Disqualifiers

None

Trial design

Design model

Parallel

Treatments tested in this trial

  • Opt-IVF

    Combination product

    Opt-IVF provides optimized dosage profile for each patient

  • Control

    Other intervention

    Physicians will decide the dosage for each day for patients

Treatment groups

200 Participants
are divided into 2 treatment groups
Group A: ControlActive comparator 1 intervention
Group B: Opt-IVFExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Total Gonadotropin Dosage

Total Gonadotropin Dosage for the cycle

Time frame
Two weeks after the start of the cycle
2

Total Oocytes Retrieved

Total Oocytes Retrieved

Time frame
Two weeks after the start of the stimulation cycle
3

M2 Oocytes

Total M2 Oocytes

Time frame
Two weeks after the start of the stimulation cycle
4

Total Embryos Formed

Total Embryos Formed

Time frame
Two weeks after the start of stimulation cycle

Secondary outcomes

1

Pregnancy Rates

Cycle pregnancy rate till the first transfer

Time frame
one month after first transfer

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Urmila DIwekar

Lead sponsor

Stochastic Research Technologies LLC

Sponsor institution

IVF Academy of USA

Collaborator

Positivf Fertility

Collaborator

Source ClinicalTrials.gov
Apply now